Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriela Kramer-Marek

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 27, 2012
The role of nuclear medicine in modern therapy of cancerGabriela Kramer-Marek, Jacek Capala
Current Pharmaceutical Design|April 20, 2012
Can PET imaging facilitate optimization of cancer therapies?Gabriela Kramer-Marek, Jacek Capala
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2023
Radiolabeled Affibody Molecules for PET ImagingChiara Da Pieve, Gabriela Kramer-Marek
Cancer Letters|August 15, 2013
Molecular imaging in pancreatic cancer--a roadmap for therapeutic decisionsGabriela Kramer-Marek, Jesse Gore, Murray Korc
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2009
Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and (18)F-labeled affibody moleculesGabriela Kramer-Marek, Dale O Kiesewetter, Jacek Capala
EJNMMI Research|July 9, 2013
Automated computer quantification of breast cancer in small-animal models using PET-guided MR image co-segmentationUlas Bagci, Gabriela Kramer-Marek, Daniel J Mollura
Biomed Research International|March 21, 2017
Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future PerspectivesWojciech Szopa, Thomas A Burley, Gabriela Kramer-Marek, et al.
Expert Opinion on Drug Delivery|September 13, 2017
Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challengesCarlos Daniel Martins, Gabriela Kramer-Marek, Wim J G Oyen
Children (Basel, Switzerland)|July 2, 2021
Novel Treatments and Technologies Applied to the Cure of NeuroblastomaIrene Paraboschi, Laura Privitera, Gabriela Kramer-Marek, et al.
Oncotargets and Therapy|May 5, 2022
Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic CombinationsMarcin Niedbała, Katarzyna Malarz, Gitanjali Sharma, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 27, 2012
The role of nuclear medicine in modern therapy of cancerGabriela Kramer-Marek, Jacek Capala
Current Pharmaceutical Design|April 20, 2012
Can PET imaging facilitate optimization of cancer therapies?Gabriela Kramer-Marek, Jacek Capala
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2023
Radiolabeled Affibody Molecules for PET ImagingChiara Da Pieve, Gabriela Kramer-Marek
Cancer Letters|August 15, 2013
Molecular imaging in pancreatic cancer--a roadmap for therapeutic decisionsGabriela Kramer-Marek, Jesse Gore, Murray Korc
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2009
Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and (18)F-labeled affibody moleculesGabriela Kramer-Marek, Dale O Kiesewetter, Jacek Capala
EJNMMI Research|July 9, 2013
Automated computer quantification of breast cancer in small-animal models using PET-guided MR image co-segmentationUlas Bagci, Gabriela Kramer-Marek, Daniel J Mollura
Biomed Research International|March 21, 2017
Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future PerspectivesWojciech Szopa, Thomas A Burley, Gabriela Kramer-Marek, et al.
Expert Opinion on Drug Delivery|September 13, 2017
Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challengesCarlos Daniel Martins, Gabriela Kramer-Marek, Wim J G Oyen
Children (Basel, Switzerland)|July 2, 2021
Novel Treatments and Technologies Applied to the Cure of NeuroblastomaIrene Paraboschi, Laura Privitera, Gabriela Kramer-Marek, et al.
Oncotargets and Therapy|May 5, 2022
Glioblastoma: Pitfalls and Opportunities of Immunotherapeutic CombinationsMarcin Niedbała, Katarzyna Malarz, Gitanjali Sharma, et al.
Pageof 5